Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
2026-06-06
·
via Latest Science News -- ScienceDaily
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。